Sotera Health Co. (SHC) Tops Q2 EPS by 3c ; Offers Guidance

Sotera Health Co. (NASDAQ: SHC) reported Q2 EPS of $0.19, $0.03 better than the analyst estimate of $0.16. Revenue for the quarter came in at $277 million versus the consensus estimate of $266.47 million.

GUIDANCE:

Sotera Health Co. sees FY2024 EPS of $0.67-$0.75, versus the consensus of $0.72.

For earnings history and earnings-related data on Sotera Health Co. (SHC) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Enanta Pharma loses appeal in Pfizer Paxlovid patent case
• NSA lost access to powerful AI model amid Anthropic dispute - NYT